US NIH National Cancer Institute: Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)

This funding opportunity calls for interdisciplinary collaborations across scientific disciplines engaged in microbiome and probiotic or prebiotic research that address the following topics: nutritional science; microbiology; virology; microecology and microbiome; genomics; immunology; computational biology; chemistry; bioengineering; integration of omics; computational approaches in DNA technologies.

Where needed, it is mandatory that the applicant proposing clinical studies provides sufficient details of plans and appropriately documented evidence of pre-investigational new drug status and other relevant regulatory correspondence.

This opportunity uses the R01 Research Project Grant funding mechanism.

Funding & Duration

Application budgets are not limited but need to reflect the actual needs of the proposed project.

The maximum period is 5 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences and tagged . Bookmark the permalink.

Comments are closed.